Private pterygium removal surgery London

What is a pterygium?

A pterygium is a wing-shaped fibrovascular growth of conjunctival tissue that extends from the bulbar conjunctiva onto the cornea, almost always from the nasal side. It is a degenerative and proliferative response of the conjunctival stem-cell niche to chronic ultraviolet (UV) light exposure, with secondary contributions from chronic dryness, wind, dust and microtrauma. Pterygia are common in patients who have lived in sunny climates, in outdoor workers, surfers, sailors, farmers and skiers, and in patients with chronic dry eye or evaporative ocular surface disease.

A pterygium is not a tumour and is not precancerous in itself. It should be distinguished histologically and clinically from ocular surface squamous neoplasia (OSSN), which can mimic pterygium and which always requires histological confirmation when atypical features are present. Other differential diagnoses include pinguecula (a yellowish conjunctival lesion that does not cross the limbus), conjunctival nevus, conjunctival lymphoma, and limbal stem cell deficiency.

• Grade 1 (atrophic) — thin, transparent, episcleral vessels visible through the lesion; lowest recurrence risk after excision.
• Grade 2 (intermediate) — partially obscures episcleral vessels.
• Grade 3 (fleshy) — thick, opaque, vascularised; obscures the underlying episcleral vessels; highest recurrence risk.

Symptoms and when a pterygium needs treatment

• Visible flesh-coloured growth on the white of the eye — typically nasal, sometimes temporal, occasionally bilateral.
• Redness and recurrent inflammation — episodes of pterygitis with hyperaemia, photophobia and tearing, often triggered by dust, wind, contact lens wear or UV exposure.
• Foreign body sensation and grittiness — the elevated leading edge disrupts the tear film.
• Induced astigmatism and blurred vision — as the pterygium approaches the visual axis it flattens the cornea horizontally and induces with-the-rule astigmatism, often 1.0 D to 5.0 D, which can blur vision even before the lesion crosses the pupil.
• Visual axis encroachment — once the pterygium crosses the pupillary margin, vision is directly obscured and surgery is essentially mandatory.
• Diplopia and restricted ocular motility — rare; seen with very large, scarred or recurrent pterygia that tether the medial rectus.
• Cosmetic concern — a visible nasal lesion, especially when fleshy or chronically inflamed, has a documented impact on quality-of-life questionnaires.

London 2026 pterygium removal pricing, in detail

London 2026 pterygium surgery pricing varies with the technique (autograft, mitomycin C, amniotic membrane), the size and grade of the pterygium, and whether it is a primary lesion or a recurrence. The fee should be quoted as an all-inclusive package covering the consultant cornea assessment, anterior segment OCT, corneal topography, the operation itself, the anaesthetic, the theatre and the structured 12-week ocular surface follow-up.

For pricing on related cornea and ocular surface procedures see our corneal cross-linking price guide, our dry eye IPL treatment price guide and our adult squint surgery guide (medial rectus restriction from large recurrent pterygia is sometimes managed alongside strabismus surgery).

What should be included in a private pterygium removal package in London in 2026?

• Cornea-subspecialty consultant — a UK GMC specialist registered consultant ophthalmologist with cornea and ocular surface subspecialty fellowship, doing at least 30 pterygium operations a year, with audit data available on request. The operating consultant should personally see you at the consultation.
• Comprehensive ocular surface work-up — slit-lamp examination, photo-documentation, anterior segment OCT, corneal topography (Pentacam, OCT or Placido-disc), tear film stability (TBUT), Schirmer's test, meibography where dry eye is suspected, gonioscopy if there are co-existing concerns.
• Histopathology — the excised tissue should be sent for histology in all atypical, recurrent, leukoplakic or rapidly growing lesions to exclude ocular surface squamous neoplasia.
• Pre-operative planning — written explanation of the surgical plan (technique, use of mitomycin C, use of amniotic membrane), the expected refractive change (often improvement in astigmatism by 1 to 3 dioptres in larger lesions) and the realistic recurrence risk (under 5 per cent with autograft, higher in recurrent or high-risk cases).
• Day-case operation — consultant-delivered surgery in a CQC-registered London theatre under topical or sub-Tenon's anaesthetic. General anaesthetic is rarely needed in adults.
• Adjuncts where indicated — mitomycin C 0.02 per cent for 1 to 3 minutes in recurrent or aggressive disease; amniotic membrane transplant for large defects or limited donor conjunctiva.
• Structured 12-week ocular surface follow-up — day-1, week-1, week-4 and week-12 consultant reviews; corneal topography at 6 weeks; suture removal if non-absorbable; long-term sun protection and lubricant counselling.
• CQC-registered premises with the latest report rated Good or Outstanding, transparent written course pricing and direct telephone access to the consultant for 90 days post-op.
• Honest expectation-setting — about the realistic 1 to 5 per cent recurrence rate for primary autograft surgery, the higher rate in recurrent disease, the 4 to 8 week red-eye phase and the lifelong need for sun protection.

Surgical techniques for pterygium removal in modern London practice

• Conjunctival autograft (CAG) — current gold standard. After excision of the pterygium head and body, a free conjunctival graft is harvested from the superior bulbar conjunctiva and transposed onto the scleral bed. Fixation is with either fibrin glue (Tisseel, Evicel) or 10/0 nylon sutures. Recurrence under 5 per cent in published series.
• Conjunctival-limbal autograft (CLAG) — the autograft includes a 1 to 2 mm rim of limbal tissue to replenish the limbal stem-cell barrier; preferred in recurrent disease and in younger patients.
• Pterygium Extended Removal Followed by Extended Conjunctival Transplant (PERFECT) technique — described by Hirst; very wide excision down to bare sclera with a large conjunctival autograft; published recurrence rate under 1 per cent in selected hands.
• Fibrin glue vs sutures — fibrin glue is associated with shorter operating time, less postoperative pain and similar (or lower) recurrence rates compared with 10/0 nylon sutures in the Cochrane systematic review.
• Intra-operative mitomycin C — 0.02 per cent MMC applied for 1 to 3 minutes to the scleral bed in recurrent or aggressive primary disease; reduces recurrence further but carries small risks of scleral melt and late ischaemia, so used selectively.
• Amniotic membrane transplant (AMT) — single or double-layer human amniotic membrane (Omnigen, Amnioguard, AmbioDisk) used as a substrate for re-epithelialisation in large defects, recurrent disease, or where donor conjunctiva is limited (e.g. after trabeculectomy).
• Bare sclera — excision without grafting; recurrence rate 30 to 80 per cent; considered substandard in modern UK practice.
• Beta irradiation, thiotepa, 5-FU — historical adjuncts; no longer used in modern UK practice.

What does the evidence say about pterygium surgery?

The evidence base for pterygium surgery is substantial and the message is consistent across the major datasets:

• Cochrane systematic review on conjunctival autograft versus amniotic membrane transplant (Clearfield, Muthappan, Lin and Kuo, 2016 update) — concluded conjunctival autograft has significantly lower recurrence than amniotic membrane transplant for primary pterygium (relative risk approximately 0.47), and that autograft remains the technique of choice for primary disease.
• Cochrane review on mitomycin C in primary pterygium surgery (Kaufman, et al.) — found low-to-moderate-certainty evidence that intra-operative MMC reduces recurrence further when combined with excision, with rare but recognised risks of scleral melt and late ischaemia.
• Royal College of Ophthalmologists Cornea standards — recommend conjunctival autograft as the standard primary technique, with mitomycin C and amniotic membrane reserved for recurrent or high-risk cases.
• American Academy of Ophthalmology BCSC (Section 8, External Disease and Cornea) — same recommendations; emphasises histological assessment of atypical lesions to exclude OSSN.
• Hirst PERFECT technique publications — report recurrence rates under 1 per cent in selected hands; not always reproducible in non-specialist series but illustrates that meticulous, extensive excision and a large autograft minimises recurrence.
• Refractive impact data — published series show improvement of corneal astigmatism by 1 to 3 dioptres after excision in lesions of grade 2 to 3, with measurable visual acuity gain.

In short: excision with conjunctival autograft is the standard technique; recurrence under 5 per cent in primary disease; mitomycin C and amniotic membrane are useful adjuncts in selected cases; histology should always be sent in atypical or recurrent lesions.

Who is a good candidate for pterygium surgery?

Not every pterygium needs surgery. The case for excision is strongest when one or more of the following apply:

• Visual axis encroachment — pterygium that has crossed or is approaching the pupillary margin; surgery is essentially mandatory.
• Induced astigmatism — topography-confirmed corneal astigmatism induced by the pterygium (often more than 1.5 D) causing significant blur or unable to be corrected adequately by spectacles.
• Recurrent or chronic inflammation — repeated episodes of pterygitis poorly controlled with topical lubricants and short courses of weak topical steroid.
• Restricted ocular motility — tethering of the medial rectus by a large or recurrent pterygium causing diplopia in lateral gaze.
• Cosmetic concern with documented quality-of-life impact — a chronically inflamed or fleshy visible nasal lesion in a patient for whom this has measurable social or occupational impact.
• Atypical features — leukoplakia, papillomatous surface, rapid growth, asymmetric appearance, or any suspicion of ocular surface squamous neoplasia — biopsy and excisional surgery with histology.
• Pre-cataract surgery — large pterygia close to the visual axis should be excised first and allowed to stabilise for 6 to 12 weeks before cataract biometry, because they distort keratometry.

Pterygium surgery is not usually advised when the lesion is small, stable, asymptomatic, not affecting the visual axis or corneal topography, and managed adequately with sun protection, lubricants and intermittent weak topical steroid. Suitability is always confirmed at consultation.

NHS vs private pterygium surgery in London 2026

NHS access to pterygium surgery in London in 2026 is variable. ICBs broadly commission surgery where the pterygium is visually threatening, inducing significant astigmatism, recurrently inflamed despite conservative care, or restricting ocular motility. Most London ICBs treat cosmetic-only pterygium surgery as restricted unless there is documented quality-of-life impact.

Realistic 2026 NHS waiting times in the London cornea pathway run between 18 and 40 weeks from referral to surgery, depending on the trust and the complexity of the case. Routine primary autograft surgery can often be done within the 18-week RTT target; recurrent or complex cases requiring amniotic membrane or symblepharon release can wait substantially longer.

Private pterygium surgery in London is the practical route when surgery within 2 to 6 weeks rather than 18 to 40 weeks matters, when cataract surgery is planned and the pterygium needs to be excised first so the biometry can be repeated cleanly, or when the patient wants the consultant cornea subspecialist of their choice to perform the operation under topical anaesthetic in a dedicated CQC theatre. Most CQC-registered London cornea centres can complete the consultation, surgery and 12-week ocular surface follow-up within an 8 to 14 week window.

Does private medical insurance cover pterygium surgery?

In 2026 the major UK private medical insurers (Bupa, AXA Health, Aviva, Vitality, WPA) generally cover pterygium removal surgery when there is documented visual symptoms (induced astigmatism, encroachment on the visual axis), chronic or recurrent inflammation, restricted ocular motility, or atypical features requiring exclusion of OSSN. The consultation, the surgery itself, the consultant fee, the anaesthetist fee where used and the day-case stay are usually covered subject to your policy excess and benefit limits.

Insurers usually do not cover pterygium surgery that is documented in the records as "cosmetic only". The clinical letter must clearly document the functional symptoms (visual symptoms, recurrent inflammation, induced astigmatism on topography, motility restriction), the impact on activities of daily living, and the failure or unsuitability of conservative options (lubricants, sun protection, weak topical steroid). Always pre-authorise in writing and ask the clinic to send the insurer the corneal topography report and slit-lamp photographs.

Risks and side-effects of pterygium surgery

Pterygium surgery is generally very safe in trained hands. The realistic risks are mostly minor and transient, but they should be set out honestly:

• Recurrence — under 5 per cent with primary autograft surgery, 5 to 15 per cent with intra-operative mitomycin C in recurrent disease, 30 to 80 per cent with the obsolete bare-sclera technique.
• Subconjunctival haemorrhage — almost universal, settles in 7 to 14 days.
• Conjunctival redness, irritation and gritty foreign-body sensation — for 4 to 8 weeks; absorbable or 10/0 nylon suture knots can poke as they dissolve or until they are removed.
• Graft displacement, retraction or dehiscence — uncommon (under 5 per cent) with fibrin glue; usually managed with re-suturing if recognised early.
• Pyogenic granuloma at the suture site — benign, manageable with topical steroid or excision in clinic.
• Dellen (corneal dryness adjacent to the operation) — transient; treated with lubricants.
• Corneal scarring — small superficial scar at the original pterygium head; usually visually inconsequential.
• Persistent astigmatism — in some cases the corneal topography does not fully normalise; spectacle or contact lens correction can be needed.
• Scleral melt and ischaemia — rare but recognised with intra-operative mitomycin C; minimised by accurate dose (0.02 per cent for 1 to 3 minutes) and copious irrigation.
• Infection (microbial keratitis, endophthalmitis) — rare (under 1 per 1000) with topical antibiotic prophylaxis.
• Diplopia — transient in the immediate postoperative period; persistent only if there has been medial rectus damage in a very large or recurrent case.
• Symblepharon (adhesions between the conjunctiva and the eyelid) — rare; more likely in recurrent surgery; managed with topical steroid, mitomycin C or symblepharon release.
• Donor site complications — cyst or granuloma at the superior conjunctival harvest site; usually self-limiting or excised in clinic.

What to expect after pterygium surgery

• Day 0 (day of surgery) — you go home the same day. The eye feels gritty, may water and is bloodshot; an eye shield is worn overnight; oral analgesia (paracetamol or ibuprofen) is usually all that is needed.
• Day 1 — review with the operating consultant. Drops start: combination antibiotic-steroid four times daily and preservative-free lubricants every 1 to 2 hours.
• Days 2–7 — back to office work, screen use and gentle activities. Avoid swimming, contact sports, dusty environments, eye rubbing and contact lens wear for 4 to 6 weeks. Wear good wraparound UV-blocking sunglasses outdoors.
• Week 1 review — graft inspection; topical steroid is tapered slowly over 6 to 8 weeks.
• Weeks 2–4 — conjunctival redness fades, suture knots dissolve or are removed at week 2 to 3 if non-absorbable.
• Week 6 review — corneal topography to confirm reduction of astigmatism; refractive update if needed.
• Month 3 review — final ocular surface review; long-term sun protection and lubricant counselling.
• Long term — lifelong daily UV-blocking sunglasses are the single most important step in reducing recurrence. Annual review for the first 2 years to check for any signs of recurrence.

How to choose a London pterygium surgery clinic in 2026

• Clinical leadership — a UK GMC specialist registered consultant ophthalmologist with documented cornea and ocular surface subspecialty fellowship, doing at least 30 pterygium operations a year, with audit data on recurrence available on request.
• Cornea-subspecialty workup — anterior segment OCT, corneal topography (Pentacam, OCT or Placido-disc) and slit-lamp photo-documentation routinely.
• Modern technique — conjunctival autograft (CAG) or conjunctival-limbal autograft (CLAG) with fibrin glue or 10/0 nylon, not the obsolete bare-sclera technique.
• Adjunct availability — intra-operative mitomycin C and amniotic membrane transplant available for recurrent or aggressive cases.
• Histology routinely sent in atypical, recurrent, leukoplakic or rapidly growing lesions to exclude OSSN.
• Honest evidence-based consent — written information about the recurrence rate (under 5 per cent with primary autograft, higher in recurrent disease), the 4 to 8 week red-eye phase and the lifelong need for sun protection.
• Transparent itemised pricing — the invoice should split consultation, surgery, histology, theatre and post-operative ocular surface follow-up so you can claim the appropriate components on insurance.
• CQC-registered theatre with a published Good or Outstanding rating, and the surgeon listed on the Royal College of Ophthalmologists' National Ophthalmology Database (NOD) audit when relevant.
• Same surgeon throughout — consultation, theatre and 3-month post-operative care done by the same consultant.
• Direct access — a published 24/7 number for postoperative concerns and a same-day clinic slot if anything changes in the first 90 days.

Frequently asked questions

How much does private pterygium surgery cost in London in 2026?

London 2026 self-pay pterygium surgery costs 2,400 to 4,200 pounds per eye for simple excision (rarely used in modern practice), 3,200 to 5,800 pounds per eye for excision plus conjunctival autograft (the gold standard), and 3,800 to 6,500 pounds per eye for excision plus autograft plus intra-operative mitomycin C in recurrent or aggressive disease at CQC-registered London cornea centres. The fee covers the consultant cornea and ocular surface assessment, anterior segment OCT, corneal topography, day-case operation under topical or sub-Tenon's anaesthetic, the operating consultant fee, the theatre and the structured 12-week ocular surface follow-up. Amniotic membrane transplant adds 850 to 1,500 pounds. Histology of the excised tissue adds 150 to 350 pounds and should be sent in all atypical or recurrent lesions.

Does a pterygium always need to be removed?

No. Many small, stable, asymptomatic pterygia can be safely observed with sun protection (UV-blocking wraparound sunglasses), preservative-free lubricants and intermittent short courses of weak topical steroid for flare-ups. Surgery is indicated when the lesion is visually threatening (encroaching on the visual axis), inducing significant corneal astigmatism, recurrently inflamed despite conservative care, restricting ocular motility, or has atypical features that require histology to exclude ocular surface squamous neoplasia.

What is the chance my pterygium will come back after surgery?

With modern excision plus conjunctival autograft, the recurrence rate is under 5 per cent in published series. With intra-operative mitomycin C in recurrent or aggressive cases the rate stays low. With the obsolete bare-sclera technique (excision alone, without grafting) the recurrence rate is 30 to 80 per cent and this technique is no longer offered in mainstream UK practice. Lifelong daily UV-blocking sunglasses are the single most important factor in reducing recurrence after surgery.

Will the NHS pay for my pterygium surgery?

NHS access to pterygium surgery in London in 2026 is variable by ICB. Surgery is routinely commissioned where the pterygium is visually threatening, inducing significant astigmatism (typically more than 1.5 D), recurrently inflamed, or restricting ocular motility. Cosmetic-only pterygium surgery is treated as restricted in most London ICBs unless there is documented quality-of-life impact. NHS waits in the London cornea pathway run between 18 and 40 weeks from referral.

Will my private medical insurance cover pterygium surgery?

In 2026 Bupa, AXA, Aviva, Vitality and WPA generally cover pterygium removal surgery when there is documented visual symptoms (induced astigmatism, encroachment on the visual axis), chronic or recurrent inflammation, restricted ocular motility, or atypical features requiring histological exclusion of ocular surface squamous neoplasia. The clinical letter must clearly document the functional symptoms, the topographic astigmatism, the impact on activities of daily living and the failure or unsuitability of conservative options. Insurers usually do not cover pterygium surgery documented in the records as cosmetic only. Always pre-authorise in writing.

Does pterygium surgery hurt and how long does it take?

Pterygium surgery is a day-case operation that takes about 25 to 45 minutes per eye under topical or sub-Tenon's anaesthetic. The skin of the eyelid is not cut. The eye feels gritty and may water for the first 4 to 8 weeks; oral paracetamol or ibuprofen is usually all that is needed for the first few days. There is no visible scar in the long term: the conjunctival incision heals invisibly and the small corneal scar at the original pterygium head is rarely noticeable. You go home the same day.

What is the difference between fibrin glue and sutures for the autograft?

Both are well-established methods of fixing the conjunctival autograft to the scleral bed. Fibrin glue (Tisseel, Evicel) is associated with shorter operating time, less postoperative pain and similar or slightly lower recurrence rates than 10/0 nylon sutures, per the Cochrane systematic review. Sutures are slightly cheaper, suitable when fibrin glue is contraindicated (e.g. severe allergy to blood-product components) and remain a perfectly acceptable alternative. The choice is usually surgeon preference plus the clinical context of the case.

Is intra-operative mitomycin C safe?

In modern practice intra-operative mitomycin C at 0.02 per cent for 1 to 3 minutes, applied to the scleral bed and copiously irrigated, is generally safe and effective in reducing recurrence in high-risk cases (recurrent pterygium, fleshy primary disease, younger patients). The rare but recognised risks are scleral melt, late ischaemia, persistent epithelial defect and corneal endothelial decompensation. Modern protocols (lower dose, shorter exposure, sponge technique, copious irrigation) have substantially reduced these risks compared to older high-dose protocols.

When can I drive after pterygium surgery?

Most patients drive 24 to 48 hours after surgery if the better eye is unaffected and they meet the DVLA standard (read a number plate at 20 metres with both eyes open and any usual spectacles). Vision in the operated eye is often slightly blurred for 1 to 2 weeks from postoperative ocular surface irregularity, but the unaffected fellow eye usually allows driving. If both eyes have been operated in the same session (unusual), driving should be deferred for 7 to 14 days.

Will I have a visible scar after pterygium surgery?

No. Modern pterygium surgery with a conjunctival autograft heals so well that the autograft becomes almost invisible by 3 to 6 months, blending with the surrounding bulbar conjunctiva. There is a small superficial corneal scar at the original pterygium head, which is rarely visible to others and is rarely visually significant. The skin of the eyelid is not cut.

Should I have my pterygium removed before cataract surgery?

Yes, in most cases. A large pterygium near the visual axis distorts corneal topography and keratometry, which makes IOL biometry inaccurate and risks an unexpected refractive surprise after cataract surgery. Best practice is to excise the pterygium first, let the cornea stabilise for 6 to 12 weeks, repeat the topography and keratometry, and then proceed with cataract surgery. See our cataract surgery price guide for the next step in the pathway.

How do I reduce the chance of getting a pterygium again?

Lifelong daily UV-blocking wraparound sunglasses are the single most important step. Wide-brimmed hats outdoors, preservative-free lubricants if there is dry eye, avoidance of dusty and windy environments where possible, and prompt management of ocular surface inflammation all reduce the risk of recurrence. Annual review for the first 2 years after surgery is recommended to catch any early recurrence while it is still small.

Methodology and sources

This London 2026 patient pricing and pathway guide was prepared by the Eye Surgery Clinic editorial team and reviewed by a UK GMC-registered consultant ophthalmologist with cornea and ocular surface subspecialty interest. Pricing reflects a CQC-registered London cornea sample audited against published 2024 to 2026 self-pay tariffs from the major London cornea providers. Clinical statements are anchored on:

• Royal College of Ophthalmologists Cornea and External Eye Disease clinical standards
• American Academy of Ophthalmology Basic and Clinical Science Course Section 8 (External Disease and Cornea)
• Cornea Society consensus statements on pterygium and ocular surface surgery
• Cochrane Database of Systematic Reviews — Clearfield E, Muthappan V, Lin X, Kuo IC. Conjunctival autograft for pterygium (2016 update)
• Cochrane Database of Systematic Reviews — Mitomycin C in primary pterygium surgery
• Hirst LW — The Pterygium Extended Removal Followed by Extended Conjunctival Transplant (PERFECT) technique series
• NICE clinical knowledge summaries on red eye, conjunctival lesions and pterygium
• UK National Ophthalmology Database (NOD) cornea audit cross-references
• Care Quality Commission (CQC) inspection reports for major London cornea units
• General Medical Council (GMC) Good Medical Practice and consent guidance

This page is editorial and educational. It is not personalised medical advice. Pterygium surgery suitability can only be confirmed by an in-person consultant cornea and ocular surface consultation with a full work-up.

Book your London pterygium consultation

Speak directly to a UK GMC-registered consultant ophthalmologist with cornea and ocular surface subspecialty interest. Same-week consultation slots are usually available. Anterior segment OCT, corneal topography and slit-lamp photo-documentation included. Confidential, no-obligation review of whether observation, surgery, mitomycin C or amniotic membrane is right for you.

Related reading: Private corneal cross-linking cost UK · Private dry eye IPL treatment cost UK · Private cataract surgery prices · Adult squint surgery London